FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054064131> ?p ?o ?g. }

• W2054064131 endingPage "61" @default.
• W2054064131 startingPage "48" @default.
• W2054064131 abstract "For effective ovarian cancer gene therapy, systemic administrated tumor-targeting siRNA/folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate (FA-PEG-COL) nanoparticles is vital for delivery to cancer site(s). siRNA/FA-PEG-COL nanoparticles were prepared by ionic gelation for effective FA receptor-expressing ovarian cancer cells transfection and in vivo accumulation. The chemical structure of FA-PEG-COL conjugate was characterized by MALDI-TOF-MS, FT-IR and (1)H NMR. The average size of siRNA/FA-PEG-COL nanoparticles was approximately 200 nm, and the surface charge was +8.4 mV compared to +30.5 mV with siRNA/COL nanoparticles. FA-PEG-COL nanoparticles demonstrated superior compatibility with erythrocytes in terms of degree of aggregation and haemolytic activity and also effects on cell viability was lower when compared with COL nanoparticles. FA grafting significantly facilitated the uptake of nanoparticles via receptor mediated endocytosis as demonstrated by flow cytometry. The in vitro transfection and gene knockdown efficiency of HIF-1α were superior to COL nanoparticles (76-62%, respectively) and was comparable to Lipofectamine 2000 (79%) as demonstrated by RT-qPCR and Western blot. Gene knockdown at the molecular level translated into effective inhibition of proliferation in vitro. Accumulation efficiency of FA-PEG-COL nanoparticles was investigated in BALB/c mice bearing OVK18 #2 tumor xenograft using in vivo imaging. The active targeting FA-PEG-COL nanoparticles showed significantly greater accumulation than the passive targeting COL nanoparticles. Based on the results obtained, siRNA/FA-PEG-COL nanoparticles show much potential for effective ovarian cancer treatment via gene therapy." @default.
• W2054064131 created "2016-06-24" @default.
• W2054064131 creator A5014645174 @default.
• W2054064131 creator A5030242147 @default.
• W2054064131 creator A5078795928 @default.
• W2054064131 date "2014-02-01" @default.
• W2054064131 modified "2023-10-18" @default.
• W2054064131 title "Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid–poly(ethylene glycol)–chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy" @default.
• W2054064131 cites W1581889893 @default.
• W2054064131 cites W1582634852 @default.
• W2054064131 cites W1964836370 @default.
• W2054064131 cites W1971645600 @default.
• W2054064131 cites W1985630151 @default.
• W2054064131 cites W1987905566 @default.
• W2054064131 cites W1996390251 @default.
• W2054064131 cites W1996442711 @default.
• W2054064131 cites W2000241413 @default.
• W2054064131 cites W2008028087 @default.
• W2054064131 cites W2011251767 @default.
• W2054064131 cites W2014509855 @default.
• W2054064131 cites W2018281666 @default.
• W2054064131 cites W2020923434 @default.
• W2054064131 cites W2021422667 @default.
• W2054064131 cites W2023854423 @default.
• W2054064131 cites W2030304300 @default.
• W2054064131 cites W2032128015 @default.
• W2054064131 cites W2045740039 @default.
• W2054064131 cites W2049490668 @default.
• W2054064131 cites W2060254175 @default.
• W2054064131 cites W2060459188 @default.
• W2054064131 cites W2063315774 @default.
• W2054064131 cites W2064100334 @default.
• W2054064131 cites W2064184046 @default.
• W2054064131 cites W2068307136 @default.
• W2054064131 cites W2073056087 @default.
• W2054064131 cites W2073408658 @default.
• W2054064131 cites W2080726302 @default.
• W2054064131 cites W2082058951 @default.
• W2054064131 cites W2086069830 @default.
• W2054064131 cites W2093037575 @default.
• W2054064131 cites W2106169256 @default.
• W2054064131 cites W2107910518 @default.
• W2054064131 cites W2124454872 @default.
• W2054064131 cites W2129462207 @default.
• W2054064131 cites W2138412834 @default.
• W2054064131 cites W2155239981 @default.
• W2054064131 cites W2160251401 @default.
• W2054064131 doi "https://doi.org/10.1016/j.ejps.2013.10.011" @default.
• W2054064131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24178005" @default.
• W2054064131 hasPublicationYear "2014" @default.
• W2054064131 type Work @default.
• W2054064131 sameAs 2054064131 @default.
• W2054064131 citedByCount "92" @default.
• W2054064131 countsByYear W20540641312014 @default.
• W2054064131 countsByYear W20540641312015 @default.
• W2054064131 countsByYear W20540641312016 @default.
• W2054064131 countsByYear W20540641312017 @default.
• W2054064131 countsByYear W20540641312018 @default.
• W2054064131 countsByYear W20540641312019 @default.
• W2054064131 countsByYear W20540641312020 @default.
• W2054064131 countsByYear W20540641312021 @default.
• W2054064131 countsByYear W20540641312022 @default.
• W2054064131 countsByYear W20540641312023 @default.
• W2054064131 crossrefType "journal-article" @default.
• W2054064131 hasAuthorship W2054064131A5014645174 @default.
• W2054064131 hasAuthorship W2054064131A5030242147 @default.
• W2054064131 hasAuthorship W2054064131A5078795928 @default.
• W2054064131 hasConcept C10138342 @default.
• W2054064131 hasConcept C104317684 @default.
• W2054064131 hasConcept C121608353 @default.
• W2054064131 hasConcept C12554922 @default.
• W2054064131 hasConcept C135983454 @default.
• W2054064131 hasConcept C150903083 @default.
• W2054064131 hasConcept C153911025 @default.
• W2054064131 hasConcept C162324750 @default.
• W2054064131 hasConcept C173396325 @default.
• W2054064131 hasConcept C178790620 @default.
• W2054064131 hasConcept C185592680 @default.
• W2054064131 hasConcept C190283241 @default.
• W2054064131 hasConcept C207001950 @default.
• W2054064131 hasConcept C2777516009 @default.
• W2054064131 hasConcept C2780306303 @default.
• W2054064131 hasConcept C40767141 @default.
• W2054064131 hasConcept C49923114 @default.
• W2054064131 hasConcept C54009773 @default.
• W2054064131 hasConcept C54355233 @default.
• W2054064131 hasConcept C54400483 @default.
• W2054064131 hasConcept C55493867 @default.
• W2054064131 hasConcept C86803240 @default.
• W2054064131 hasConcept C92087593 @default.
• W2054064131 hasConcept C96232424 @default.
• W2054064131 hasConceptScore W2054064131C10138342 @default.
• W2054064131 hasConceptScore W2054064131C104317684 @default.
• W2054064131 hasConceptScore W2054064131C121608353 @default.
• W2054064131 hasConceptScore W2054064131C12554922 @default.
• W2054064131 hasConceptScore W2054064131C135983454 @default.
• W2054064131 hasConceptScore W2054064131C150903083 @default.
• W2054064131 hasConceptScore W2054064131C153911025 @default.

• next